Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial.
Geyer T, Kazmierczak PM, Steffen IG, Malfertheiner P, Peynircioglu B, Loewe C, Delden OV, Vandecaveye V, Gebauer B, Pech M, Sengel C, Bargellini I, Iezzi R, Benito A, Zech CJ, Gasbarrini A, Schütte K, Ricke J, Seidensticker M. Geyer T, et al. Among authors: benito a. Biomedicines. 2022 May 18;10(5):1156. doi: 10.3390/biomedicines10051156. Biomedicines. 2022. PMID: 35625900 Free PMC article.
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma.
Kolligs FT, Bilbao JI, Jakobs T, Iñarrairaegui M, Nagel JM, Rodriguez M, Haug A, D'Avola D, op den Winkel M, Martinez-Cuesta A, Trumm C, Benito A, Tatsch K, Zech CJ, Hoffmann RT, Sangro B. Kolligs FT, et al. Among authors: benito a. Liver Int. 2015 Jun;35(6):1715-21. doi: 10.1111/liv.12750. Epub 2015 Jan 17. Liver Int. 2015. PMID: 25443863 Clinical Trial.
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: benito a. Eur Radiol. 2022 Feb;32(2):1320-1329. doi: 10.1007/s00330-021-08218-9. Epub 2021 Aug 31. Eur Radiol. 2022. PMID: 34467453 Free PMC article.
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma.
Öcal O, Ingrisch M, Ümütlü MR, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: benito a. Br J Cancer. 2022 Feb;126(2):211-218. doi: 10.1038/s41416-021-01577-6. Epub 2021 Oct 22. Br J Cancer. 2022. PMID: 34686780 Free PMC article. Clinical Trial.
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort.
Seidensticker M, Steffen IG, Bargellini I, Berg T, Benito A, Gebauer B, Iezzi R, Loewe C, Karçaaltincaba M, Pech M, Sengel C, van Delden O, Vandecaveye V, Zech CJ, Ricke J. Seidensticker M, et al. Among authors: benito a. Curr Oncol. 2022 Jan 27;29(2):565-577. doi: 10.3390/curroncol29020051. Curr Oncol. 2022. PMID: 35200551 Free PMC article. Clinical Trial.
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression.
Öcal O, Zech CJ, Fabritius MP, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Berg T, Sengel C, Bargellini I, Iezzi R, Benito A, Pech M, Gasbarrini A, Sangro B, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: benito a. Eur Radiol. 2023 Jan;33(1):493-500. doi: 10.1007/s00330-022-09000-1. Epub 2022 Jul 26. Eur Radiol. 2023. PMID: 35881180 Free PMC article. Clinical Trial.
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.
D'Avola D, Iñarrairaegui M, Pardo F, Rotellar F, Marti P, Bilbao JI, Martinez-Cuesta A, Benito A, Alegre F, Mauleón E, Herrero JI, Quiroga J, Prieto J, Sangro B. D'Avola D, et al. Among authors: benito a. Ann Surg Oncol. 2011 Jul;18(7):1964-71. doi: 10.1245/s10434-011-1551-4. Epub 2011 Jan 26. Ann Surg Oncol. 2011. PMID: 21267791
Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.
Iñarrairaegui M, Martinez-Cuesta A, Rodríguez M, Bilbao JI, Arbizu J, Benito A, Alegre F, D'Avola D, Herrero JI, Quiroga J, Prieto J, Sangro B. Iñarrairaegui M, et al. Among authors: benito a. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1441-8. doi: 10.1016/j.ijrobp.2009.07.006. Epub 2010 Jan 7. Int J Radiat Oncol Biol Phys. 2010. PMID: 20056355
636 results